iSpecimen Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 112.1%.

Top 13 shareholders own 20.01% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.89%	Andrew Ross	66,317	US$294.4k	0%	no data
4.37%	Obf Investments, LLC	42,099	US$186.9k	0%	no data
4.11%	James Wolf	39,537	US$175.5k	0%	no data
2.27%	Jane Street Group, LLC, Asset Management Arm	21,895	US$97.2k	2,100%	no data
1.19%	FNY Investment Advisers, LLC	11,500	US$51.1k	0%	0.02%
0.39%	Benjamin Bielak	3,744	US$16.6k	0%	no data
0.29%	BlackRock, Inc.	2,827	US$12.6k	0.04%	no data
0.18%	Tracy Curley	1,719	US$7.6k	0%	no data
0.15%	UBS Asset Management AG	1,469	US$6.5k	0%	no data
0.12%	Tower Research Capital Europe Limited	1,168	US$5.2k	0%	no data
0.017%	John Brooks	163	US$723.6	0%	no data
0.017%	Steven Gullans	163	US$723.6	0%	no data
0.0061%	Bank of America Corporation, Asset Management Arm	59	US$262.0	2,850%	no data